TNON Stock Analysis
TN
Uncovered
Tenon Medical Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
TENON Medical, Inc. is a medical device company, which is designed to optimize sacroiliac joint fixation / fusion surgery and corresponding outcomes. The company is headquartered in Los Gatos, California and currently employs 22 full-time employees. The company went IPO on 2022-04-27. The firm has developed an inferior-posterior approach to the sacroiliac joint using a single, robust, titanium implant for the treatment of the most common types of sacroiliac joint (SI Joint) disorders that cause lower back pain. The Catamaran SI Joint Fusion System (The Catamaran System) is designed to transfix and stabilize the SI Joint. The System features the Catamaran Fixation Device, which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach are also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Company’s subsidiary is Tenon Technology AG.